Loss of PKCδ results in characteristics of Sjögren's syndrome including salivary gland dysfunction

Oral Diseases

Volumn 17, Issue 6, 2011, Pages 601-609

  Banninger, G P ^a   Cha, S ^b   Said, M S ^b   Pauley, K M ^b   Carter, C J ^a   Onate, M ^b   Pauley, B A ^b   Anderson, S M ^b   Reyland, M E ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF DENTISTRY   (United States)

Author keywords

Autoimmunity; PKC ; Sj gren's syndrome

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; CYTOKINE; GAMMA INTERFERON; PROTEIN KINASE C DELTA;

AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIBODY SCREENING; ARTICLE; B LYMPHOCYTE; CELL INFILTRATION; CELL SUBPOPULATION; EXOCRINE GLAND; IMMUNOHISTOCHEMISTRY; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SALIVARY GLAND DISEASE; SJOEGREN SYNDROME; STAINING; TISSUE INJURY;

ANIMALS; ANTIBODIES, ANTINUCLEAR; ANTIGENS, CD45; APOPTOSIS; AUTOANTIBODIES; B-LYMPHOCYTES; CELL MOVEMENT; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; FEMALE; GERMINAL CENTER; INTERFERON-GAMMA; INTERLEUKIN-4; KI-67 ANTIGEN; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; MICE, KNOCKOUT; PROTEIN KINASE C-DELTA; SALIVARY DUCTS; SECRETORY RATE; SELF TOLERANCE; SJOGREN'S SYNDROME; SUBMANDIBULAR GLAND; SUBMANDIBULAR GLAND DISEASES;

EID: 79960697290     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2011.01819.x     Document Type: Article

References (33)

1. Allen-Petersen BL, Miller MR, Neville MC et al (2010). Loss of protein kinase C delta alters mammary gland development and apoptosis. Cell Death Dis 1: e17.
2. Baker OJ, Camden JM, Redman RS et al (2008). Proinflammatory cytokines tumor necrosis factor-alpha and interferon-gamma alter tight junction structure and function in the rat parotid gland Par-C10 cell line. Am J Physiol Cell Physiol 295: C1191-C1201.
3. Bowman SJ, Ibrahim GH, Holmes G, Hamburger J, Ainsworth JR (2004). Estimating the prevalence among Caucasian women of primary Sjogren's syndrome in two general practices in Birmingham, UK. Scand J Rheumatol 33: 39-43.
4. Caulfield VL, Balmer C, Dawson LJ, Smith PM (2009). A role for nitric oxide-mediated glandular hypofunction in a non-apoptotic model for Sjogren's syndrome. Rheumatology (Oxford) 48: 727-733.
5. Cha S, Singson E, Cornelius J, Yagna JP, Knot HJ, Peck AB (2006). Muscarinic acetylcholine type-3 receptor desensitization due to chronic exposure to Sjogren's syndrome-associated autoantibodies. J Rheumatol 33: 296-306.
6. Devauchelle-Pensec V, Pennec Y, Morvan J et al (2007). Improvement of Sjogren's syndrome after two infusions of rituximab (anti-CD20). Arthritis Rheum 57: 310-317.
7. DeVries TA, Neville MC, Reyland ME (2002). Nuclear import of PKCdelta is required for apoptosis: identification of a novel nuclear import sequence. EMBO J 21: 6050-6060.
8. Fox RI, Kang HI (1992). Pathogenesis of Sjogren's syndrome. Rheum Dis Clin North Am 18: 517-538.
9. Fox RI, Kang HI, Ando D, Abrams J, Pisa E (1994). Cytokine mRNA expression in salivary gland biopsies of Sjogren's syndrome. J Immunol 152: 5532-5539.
10. Greenspan JS, Daniels TE, Talal N, Sylvester RA (1974). The histopathology of Sjogren's syndrome in labial salivary gland biopsies. Oral Surg Oral Med Oral Pathol 37: 217-229.
11. Groom J, Kalled SL, Cutler AH et al (2002). Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjogren's syndrome. J Clin Invest 109: 59-68.
12. Hansen A, Odendahl M, Reiter K et al (2002). Diminished peripheral blood memory B cells and accumulation of memory B cells in the salivary glands of patients with Sjogren's syndrome. Arthritis Rheum 46: 2160-2171.
13. Hansen A, Reiter K, Ziprian T et al (2005). Dysregulation of chemokine receptor expression and function by B cells of patients with primary Sjogren's syndrome. Arthritis Rheum 52: 2109-2119.
14. Hayashi Y, Utsuyama M, Kurashima C, Hirokawa K (1989). Spontaneous development of organ-specific autoimmune lesions in aged C57BL/6 mice. Clin Exp Immunol 78: 120-126.
15. Humphreys-Beher MG, Brayer J, Yamachika S, Peck AB, Jonsson R (1999). An alternative perspective to the immune response in autoimmune exocrinopathy: induction of functional quiescence rather than destructive autoaggression. Scand J Immunol 49: 7-10.
16. Humphries MJ, Limesand KH, Schneider JC et al (2006). Suppression of apoptosis in the protein kinase C delta null mouse in vivo. J Biol Chem 281: 9728-9737.
17. Jonsson R, Tarkowski A, Backman K, Holmdahl R, Klareskog L (1987). Sialadenitis in the MRL-l mouse: morphological and immunohistochemical characterization of resident and infiltrating cells. Immunology 60: 611-616.
18. Jonsson MV, Delaleu N, Jonsson R (2007). Animal models of Sjogren's syndrome. Clin Rev Allergy Immunol 32: 215-224.
19. Khare SD, Sarosi I, Xia XZ et al (2000). Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice. Proc Natl Acad Sci U S A 97: 3370-3375.
20. Kroneld U, Halse AK, Jonsson R, Bremell T, Tarkowski A, Carlsten H (1997). Differential immunological aberrations in patients with primary and secondary Sjogren's syndrome. Scand J Immunol 45: 698-705.
21. Mecklenbrauker I, Saijo K, Zheng NY, Leitges M, Tarakhovsky A (2002). Protein kinase Cdelta controls self-antigen-induced B-cell tolerance. Nature 416: 860-865.
22. Mecklenbrauker I, Kalled SL, Leitges M, Mackay F, Tarakhovsky A (2004). Regulation of B-cell survival by BAFF-dependent PKCdelta-mediated nuclear signalling. Nature 431: 456-461.
23. Miyamoto A, Nakayama K, Imaki H et al (2002). Increased proliferation of B cells and auto-immunity in mice lacking protein kinase Cdelta. Nature 416: 865-869.
24. Nishizuka Y (1992). Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 258: 607-614.
25. Ohyama Y, Nakamura S, Matsuzaki G et al (1996). Cytokine messenger RNA expression in the labial salivary glands of patients with Sjogren's syndrome. Arthritis Rheum 39: 1376-1384.
26. Reyland ME (2009). Protein kinase C isoforms: multi-functional regulators of cell life and death. Front Biosci 14: 2386-2399.
27. Salomonsson S, Jonsson MV, Skarstein K et al (2003). Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sjogren's syndrome. Arthritis Rheum 48: 3187-3201.
28. Soyfoo MS, Steinfeld S, Delporte C (2007). Usefulness of mouse models to study the pathogenesis of Sjogren's syndrome. Oral Dis 13: 366-375.
29. Stott DI, Hiepe F, Hummel M, Steinhauser G, Berek C (1998). Antigen-driven clonal proliferation of B cells within the target tissue of an autoimmune disease. The salivary glands of patients with Sjogren's syndrome. J Clin Invest 102: 938-946.
30. Takada K, Takiguchi M, Konno A, Inaba M (2004). Spontaneous development of multiple glandular and extraglandular lesions in aged IQI/Jic mice: a model for primary Sjogren's syndrome. Rheumatology (Oxford) 43: 858-862.
31. Ware CF (2000). APRIL and BAFF connect autoimmunity and cancer. J Exp Med 192: F35-F38.
32. White SC, Casarett GW (1974). Induction of experimental autoallergic sialadenitis. J Immunol 112: 178-185.
33. Youinou P, Devauchelle V, Hutin P, Le Berre R, Saraux A, Pers JO (2007). A conspicuous role for B cells in Sjogren's syndrome. Clin Rev Allergy Immunol 32: 231-237.